301363 美好医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)3.23110.92110.10018.22224.237
总资产报酬率 ROA (%)2.8849.7739.06615.20318.780
投入资产回报率 ROIC (%)3.10810.4939.69316.82021.769

边际利润分析
销售毛利率 (%)37.51942.07841.19143.04344.906
营业利润率 (%)17.47725.74826.29432.27230.625
息税前利润/营业总收入 (%)14.48922.66522.37028.78831.343
净利润/营业总收入 (%)15.59822.81923.42328.41027.263

收益指标分析
经营活动净收益/利润总额(%)103.768100.04697.04898.181101.606
价值变动净收益/利润总额(%)2.7672.6554.4800.1871.056
营业外收支净额/利润总额(%)0.028-0.056-0.084-0.019-0.053

偿债能力分析
流动比率 (X)6.9876.6088.6637.8922.800
速动比率 (X)5.9365.7237.2876.4811.962
资产负债率 (%)10.25811.2709.67810.83326.796
带息债务/全部投入资本 (%)2.1211.7202.1431.95311.872
股东权益/带息债务 (%)4,526.3475,602.4664,469.7154,923.764715.480
股东权益/负债合计 (%)874.804787.332933.270823.117273.192
利息保障倍数 (X)-4.841-7.385-5.733-8.27842.692

营运能力分析
应收账款周转天数 (天)86.74763.00955.98053.30757.268
存货周转天数 (天)135.277137.280184.937166.977129.600